Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
To evaluate whether the cilostazol reduce neointimal hyperplasia after ZES
(Zotarolimus-eluting stents) implantation, the investigators performed
double-blind,randomized, multicenter, prospective study compared triple antiplatelet therapy
(aspirin plus clopidogrel plus cilostazol) and dual antiplatelet therapy (aspirin plus
clopidogrel) for 8 months in patients with long coronary lesion treated with ZES.